Marketing.
Reach.
02 / The output
01 Scientific and medical writing
Manuscripts, abstracts, posters, slide decks and value communication, referenced and claim-linked.
02 Modular omnichannel content
Approved claim-and-evidence modules that assemble into email, web and field assets without restarting review.
03 Congress materials
Built to the deadline that does not move.
04 Thought leadership
Written by people who can read the trial, not paraphrase the press release.
05 Localisation
European markets, reviewed by native speakers, not machine-translated.
05 / Common questions
Do you write to MLR standards?
Yes. Everything is produced referenced and claim-linked, so medical, legal and regulatory review is checking judgement rather than chasing sources. Getting this wrong is the most common reason launch content misses its date.
What is modular content and why does it matter?
Writing approved, reusable claim-and-evidence blocks instead of finished assets, then assembling channels from them. It matters because review moves to the module, so a new email or a localised deck reuses an approved block instead of restarting the review clock.
Can you write in our voice rather than yours?
That is the default. We work under your brand, your tone of voice and your claim library. Nothing we produce is labelled as ours.
